Patricia Louis on Muck Rack

Patricia Louis

Verified
Philadelphia
As seen in: Forbes, MSN, Forbes Advisor, Forbes Health, Asbury Park Press, Le Progrès, Le Républicain Lorrain, L'Est Républicain, Vosges Matin, Our Community Now
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Patricia

Contact Patricia, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Long-Term Effects Of GLP-1 Use: Risks And Benefits

|
By Patricia Louis Verified, Jim McNett
| Forbes Health Verified
Table of Contents GLP-1 receptor agonist drugs are becoming well-known weight loss treatments. The U.S. Food and Drug Administration (FDA) has approved several GLP-1 medications from different manufacturers in recent years, such as Wegovy (semaglutide), Saxenda (liraglutide), Foundayo (orforglipron ) and Zepbound (tirzepatide) for weight management.
Open in Who Shared Issue with article?

Microdosing GLP-1s: Does It Work And Is It Safe?

|
By Patricia Louis Verified, Carley Prendergast Verified
| Forbes Health Verified
Table of Contents You may have heard about glucagon-like peptide-1 (GLP-1) receptor agonist medications like Wegovy, Zepbound, Foundayo or Saxenda, which are approved by the U.S. Food and Drug Administration (FDA) for weight loss treatment, as well as others FDA-approved for the management of type 2 diabetes, including Ozempic and Mounjaro.
Open in Who Shared Issue with article?

Semaglutide With B12: Benefits And Weight Loss, According To Experts

|
By Patricia Louis Verified, Aaliyah Pasols Verified
| Forbes Health Verified
Table of Contents Glucagon-like peptide-1 receptor agonist (GLP-1) drugs, such as semaglutide, have become well known for their ability to aid in weight loss. However, compounded versions of this drug have started to enter the market, which may pose risks to consumers, as they have not been reviewed by the U.S. Food and Drug Administration (FDA) for safety, effectiveness and quality. The only FDA-approved GLP-1 semaglutide medication for weight loss is Wegovy.
Open in Who Shared Issue with article?
See all 31 licensed articles (339 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified